Tamar Ben-Yedidia, et al. Intranasal administrationof peptide vaccine protects human/mouse radiation chimera from influenza infection. Dept. of Immunology, The Weizmann Institute Science, Rehovot, Israel. |
Francine Connan, et al. A simple assay for detection of peptides promoting the assembly of HLA class I molecules. Eur. J. Immunol. 1994. 24: 777-780. |
Jeff Alexander, et al. Derivation of HLA-A11/Kb Transgenic Mice. The American Association of Immunologists (1977). |
Tao Dong, et al. An HLA-B35-restricted epitope modified at an anchor residue results in an antagonist peptide. Eur. J. Immunol. 1996 26: 335-339. |
Sutton, Julian, et al. A sequence pattern for peptides presented to cytotoxic T lymphocytes by HLA B8 revealed by analysis of epitopes and eluted peptides. European Journal of Immunology (1993). |
Jonathan B. Rothbard, et al. Structural Model of HLA-DR1 Restricted T Cell Antigen Recognition. Cell. vol 52, 515-523. (Feb. 26, 1988). |
Raphael Levi, et al. Synthetic recombinant influenza vaccine induces efficient long-term immunity and cross-strain protection. Vaccine vol. 14, No. 1, pp. 85-92 (1996) Elsevier Sceince Ltd. |
Tamar Ben-Yedidia, et al. Efficacy of anti-influenza peptide vaccine in aged mice. Mechanisms of ageing and development, 104 (1998) 11-23. |